X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

期刊標題檢索 WIRES NANOMED N 最新評論: I have already published 4 articles in this journal, with over 200 ci... (2024-06-23)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology]您好,您是該頁面的第 30806 位訪客。

期刊簡介
期刊名稱Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
LetPub Score
7.6
50 ratings
Rate

Reputation
8.8

Influence
6.6

Speed
7.1

期刊簡稱WIRES NANOMED NANOBI
ISSN1939-5116
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
17.601.5711.271
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Medicine (miscellaneous)
Q110 / 398
Category: Medicine
Subcategory: Biomedical Engineering
Q114 / 303
Category: Medicine
Subcategory: Bioengineering
Q112 / 162

自引率 (2023-2024)1.40%自引率趨勢
掲載範囲
Nanotechnology is universally recognized as one of the most important scientific fields of the twenty-first century. Biomedical applications of this technology include nanobiotechnology and nanomedicine, one of seven emerging research areas highlighted by, and funded through, the NIH Roadmap for Medical Research. The advancement of this field relies on the combined efforts of researchers from many different backgrounds, including clinicians, biomedical engineers, materials scientists, applied physicists, and toxicologists. The need for a high-quality interdisciplinary review forum was pressing, and WIREs Nanomedicine and Nanobiotechnology looks to fill that niche. The topical coverage includes: Toxicology and regulatory issues; Implantable materials and surgical technologies; Diagnostic tools; Nanotechnology approaches to biology; Therapeutic approaches and drug discovery; Biology-inspired nanomaterials.
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1939-0041
在線稿件提交http://wires.wiley.com/WileyCDA/Section/id-398153.html
開放訪問No
出版商Wiley-Blackwell
主題領域NANOSCIENCE & NANOTECHNOLOGY
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年2008
每年文章數52每年文章數趨勢
黃金OA百分比15.89%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ121/189
NANOSCIENCE & NANOTECHNOLOGYSCIEQ133/140
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1939-5116%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Invited contributions ? Irregular
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Science Translational MedicineH-index: 168

    CiteScore: 26.70
    Stem Cell Research & TherapyH-index: 56

    CiteScore: 13.20
    EXPERT REVIEWS IN MOLECULAR MEDICINEH-index: 73

    CiteScore: 7.40
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINEH-index: 108

    CiteScore: 11.50
    Frontiers of MedicineH-index: 28

    CiteScore: 18.30
    Journal of Diabetes ResearchH-index: 33

    CiteScore: 8.40
    Biomed Research InternationalH-index: 94

    CiteScore: 6.70
    JOURNAL OF INVESTIGATIVE MEDICINEH-index: 59

    CiteScore: 11.20
    Journal of Cardiovascular Translational ResearchH-index: 44

    CiteScore: 6.10
    American Journal of Translational ResearchH-index: 45

    CiteScore: 5.30
    學科內最受檢索的期刊 頁面查看次數
    Biomed Research International398129
    Science Translational Medicine170707
    American Journal of Translational Research165370
    Stem Cell Research & Therapy136208
    Frontiers of Medicine89265
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE78945
    Journal of Diabetes Research56540
    Journal of Cardiovascular Translational Research32185
    EXPERT REVIEWS IN MOLECULAR MEDICINE17237
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION16000
  •  

    Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology] 的評論撰寫評論
作者: 半π


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-06-23 09:43:57 評論於
I have already published 4 articles in this journal, with over 200 citations. This year, I am determined to strive even harder and aim to contribute 100 citations in a single year! It is both a task and a goal, and I am not sure if it is achievable.
(0) 讚! | 半π

作者: 半π


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2022-07-17 22:03:38 評論於
It's growing a bit slowly!
(0) 讚! | 半π

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:09:04 評論於
The introduction can be seen as the state of knowledge before your research, while the conclusion is the state of knowledge after your research
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:03:21 評論於
The introduction should outline the difficulties you want to address and the questions you want to answer, summarizing existing research and gaps in knowledge
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 21:33:40 評論於
How to write an introduction? How does it differ from a discussion?
(0) 讚! | 龙鳞孝礼

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 18:32:07 評論於
The difference between introduction and discussion?
(0) 讚! | 陶宜三岁啦

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 12:24:03 評論於
Stuck at this point, it's not easy to push forward any further on this front. 4 points is satisfactory
(0) 讚! | 凌霄高洁

作者: 半荷子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-06-15 10:38:15 評論於
Review speed: 1.0 | Submission acceptance rate: 25.0
Experience sharing: The factor is very high, it seems a bit lower than last year
(0) 讚! | 半荷子

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*